Disease | neutropenia |
Symptom | C0026946|fungal infections |
Sentences | 2 |
PubMedID- 26392781 | This drug has been approved for the prevention of invasive fungal infections in patients with neutropenia and for the treatment of invasive fungal infections in hematopoietic stem cell transplant recipients with graft-versus-host disease. |
PubMedID- 23975584 | Bacterial infections are common in the early stages of neutropenia, with fungal infections emerging if neutropenia persists beyond 7-10 days. |
Page: 1